
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HCTI | -99.79% | N/A | N/A | -100% |
| S&P | +16.89% | +84.17% | +12.98% | +59% |
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded on October 29, 2019 and is headquartered in Pleasanton, CA.
No news articles found for Healthcare Triangle.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $3.49M | 44.6% |
| Gross Profit | $555.00K | 46.4% |
| Gross Margin | 15.91% | 0.2% |
| Market Cap | $15.34M | 452.4% |
| Market Cap / Employee | $168.55K | 0.0% |
| Employees | 91 | 313.6% |
| Net Income | -$1,906.00K | -52.6% |
| EBITDA | -$2,528.00K | -206.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.63M | 5717.9% |
| Accounts Receivable | $2.44M | 51.6% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $1.53M | 41.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -67.96% | -2.4% |
| Return On Invested Capital | 113.55% | 286.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,650.00K | -470.6% |
| Operating Free Cash Flow | -$1,964.00K | -374.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -0.45 | 4.21 | 14.55 | 5.53 | -462.00% |
| Price to Sales | 0.48 | 0.26 | 1.37 | 0.90 | 438.85% |
| Price to Tangible Book Value | -291.00 | -33.69 | 97.22 | -5.24 | -96.98% |
| Price to Free Cash Flow TTM | 6.94 | - | |||
| Enterprise Value to EBITDA | -15.70 | -3.13 | -15.34 | -7.52 | 61.72% |
| Free Cash Flow Yield | 14.4% | - | |||
| Return on Equity | -292.4% | -144.0% | -118.5% | -182.6% | -3.36% |
| Total Debt | $2.65M | $775.00K | $415.00K | $1.53M | 41.40% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.